Surface Oncology SURF
$ 1.07
0.0%
Quarterly report 2023-Q2
added 08-02-2023
Country |
USA |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. J. Jeffrey Goater |
Employees in the company |
49 |
Shares |
55.8 M |
Market Cap[1] |
$ 59.7 M |
EBITDA (LTM) |
$ -58.6 M |
P/E (LTM) |
-0.54 |
P/S (LTM) |
- |
EPS (LTM) |
-1.64 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.